These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 1861158

  • 1. Identification of serotonin receptors recognized by anti-idiotypic antibodies.
    Tamir H, Liu KP, Hsiung SC, Yu PY, Kirchgessner AL, Gershon MD.
    J Neurochem; 1991 Sep; 57(3):930-42. PubMed ID: 1861158
    [Abstract] [Full Text] [Related]

  • 2. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):1-12. PubMed ID: 3002805
    [Abstract] [Full Text] [Related]

  • 4. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.
    Waeber C, Schoeffter P, Palacios JM, Hoyer D.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun 26; 337(6):595-601. PubMed ID: 2975354
    [Abstract] [Full Text] [Related]

  • 5. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA, Tan GL, Hamblin MW, Ciaranello RD.
    Mol Pharmacol; 1988 Oct 26; 34(4):527-36. PubMed ID: 3139989
    [Abstract] [Full Text] [Related]

  • 6. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D, Waeber C, Pazos A, Probst A, Palacios JM.
    Neurosci Lett; 1988 Mar 10; 85(3):357-62. PubMed ID: 2966310
    [Abstract] [Full Text] [Related]

  • 7. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
    Matsumoto I, Combs MR, Jones DJ.
    J Pharmacol Exp Ther; 1992 Feb 10; 260(2):614-26. PubMed ID: 1738111
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A, Sebben M, Bockaert J.
    Mol Pharmacol; 1988 Feb 10; 33(2):178-86. PubMed ID: 2828913
    [Abstract] [Full Text] [Related]

  • 9. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord.
    Marlier L, Teilhac JR, Cerruti C, Privat A.
    Brain Res; 1991 May 31; 550(1):15-23. PubMed ID: 1832328
    [Abstract] [Full Text] [Related]

  • 10. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M, Lyon RA, Davis KH, Glennon RA.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3265-71. PubMed ID: 3663239
    [Abstract] [Full Text] [Related]

  • 11. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.
    Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan 01; 332(1):1-7. PubMed ID: 2936965
    [Abstract] [Full Text] [Related]

  • 12. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
    Pinto W, Battaglia G.
    Neuroreport; 1993 Oct 25; 5(1):61-4. PubMed ID: 8280861
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes.
    Heuring RE, Peroutka SJ.
    J Neurosci; 1987 Mar 25; 7(3):894-903. PubMed ID: 2951504
    [Abstract] [Full Text] [Related]

  • 14. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR, Murthy JN, Pluchino RS.
    J Pharmacol Exp Ther; 1992 Apr 25; 261(1):161-5. PubMed ID: 1560361
    [Abstract] [Full Text] [Related]

  • 15. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J.
    Mol Pharmacol; 1988 Dec 25; 34(6):880-7. PubMed ID: 2849052
    [Abstract] [Full Text] [Related]

  • 16. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
    Markstein R, Hoyer D, Engel G.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug 25; 333(4):335-41. PubMed ID: 2945992
    [Abstract] [Full Text] [Related]

  • 17. 5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography.
    Waeber C, Dietl MM, Hoyer D, Palacios JM.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov 25; 340(5):486-94. PubMed ID: 2533325
    [Abstract] [Full Text] [Related]

  • 18. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW, Asarch KB, Shih JC.
    J Neurochem; 1986 Jan 25; 46(1):68-75. PubMed ID: 2933490
    [Abstract] [Full Text] [Related]

  • 19. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
    Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun 25; 337(6):609-20. PubMed ID: 2905765
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a [3H]-5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D subtypes.
    Xiong WC, Nelson DL.
    Life Sci; 1989 Jun 25; 45(16):1433-42. PubMed ID: 2811600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.